1Philip J,Ragavan N,Desouza J,et al.Effect of peripheral biopsies in maximizing early prostate cancer detection in 8-,10- or 12-core biopsy regimens[J].BJU Int,2004,93(9):1218-1220.
2Eskicorapci SY,Guliyev F,Akdogan B,et al.Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection[J].J Urol,2005 ,173(5):1536-1540.
4Irani J, Fournier F, Bon D, et al. Patient tolerance of transrectal ultrasound guided biopsy of the prostate. Br J Urol, 1997,79:608- 610.
5Kapoor DA,Klimberg IW, Malek GH, et al. Single-dose oral ciprofl oxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology, 1998,52 : 552-528.
6Djavan B,Waldert M, Zlotta A, et al. Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of prospective European prostate cancer detection study. J Urol,2001,166:856-860.
7Raaijmakers R, Kirkels WJ, Roobol MJ, et al. Complication rates and risk factors of 5802 transreetal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology, 2002,60: 826-830.
8Aus G, Ahlgren G, Bergdahl S, et al. Infection after transrectal core biopsies of the prostate risk factors and antibiotic prophylaxis. Br J Urol, 1996,77 : 851-855.
9Rietbergen JB, Kruger AE, Kranse R, et al. Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate:evaluation of complication rates and risk factors within a population-based screening program. Urology, 1997,49 : 875- 880.
10Naughton CK, Miller DC, Mager DE, et al. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol,2000,164:388- 392.
